home

Home> Industry News >R&D >Main Body

Industry News

Ophthotech Completes Patient Recruitment of the Second Phase 3 Pivotal Trial of Fovista® Anti-PDGF Therapy in Combination with Lucentis® in Wet Age-Related Macular Degeneration

2015-10-28 17:22

Source：Ophthotech

Read：411 Favorite 0

Share

相关阅读

You may interest

Copyright©2020 药渡经纬信息科技（北京）有限公司电子与信息服务业务经营许可证151001号

京ICP备14047345| 京公安网备11010802017043号 |（京）-经营性-2015-0023（互联网药品信息服务资格证书）

: 药渡APP

: 微信二维码